Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group

Overall survival of children and adolescents with mature B cell non-Hodgkin lymphoma who had refractory or relapsed disease during or after treatment with FAB/LMB 96: A report from the FAB/LMB 96 study group. Cairo, M.; Auperin, A.; Perkins, S. L.; Pinkerton, R.; Harrison, L.; Goldman, S.; Patte, C.. Br J Haematol. 2018; 859-869: p.859-869. doi:10.1111/bjh.15491
Article